Product NDC: | 23155-216 |
Proprietary Name: | CIDOFOVIR DIHYDRATE |
Non Proprietary Name: | CIDOFOVIR DIHYDRATE |
Active Ingredient(s): | 375 mg/5mL & nbsp; CIDOFOVIR DIHYDRATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 23155-216 |
Labeler Name: | Heritage Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202501 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120806 |
Package NDC: | 23155-216-31 |
Package Description: | 5 mL in 1 VIAL, GLASS (23155-216-31) |
NDC Code | 23155-216-31 |
Proprietary Name | CIDOFOVIR DIHYDRATE |
Package Description | 5 mL in 1 VIAL, GLASS (23155-216-31) |
Product NDC | 23155-216 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CIDOFOVIR DIHYDRATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120806 |
Marketing Category Name | ANDA |
Labeler Name | Heritage Pharmaceuticals Inc. |
Substance Name | CIDOFOVIR |
Strength Number | 375 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] |